This company seems to have been delisted
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
Reason: Filed for Bankruptcy
Last recorded trade on: September 27, 2023
Source: https://www.fiercebiotech.com/medtech/viewray-eyes-sale-mri-guided-radiotherapy-tech-wake-bankruptcy-filing
ViewRay
VRAY
HK$0.19
Share price
0.00%
Change (1 day)
-99.28%
Change (1 year)
Categories
Earnings for ViewRay (VRAY)
Earnings in 2023 (TTM): -HK$0.87 Billion
According to ViewRay's latest financial reports the company's current earnings are HK$0.10 Billion. In 2022 the company made an earning of -HK$0.84 Billion, an increase over its 2021 earnings that were of -HK$0.86 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for ViewRay from 2014 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -HK$0.87 Billion | 3.93% |
| 2022 | -HK$0.84 Billion | -2.47% |
| 2021 | -HK$0.86 Billion | 1.98% |
| 2020 | -HK$0.84 Billion | -10.23% |
| 2019 | -HK$0.94 Billion | 57.34% |
| 2018 | -HK$0.6 Billion | 5.85% |
| 2017 | -HK$0.57 Billion | 42.54% |
| 2016 | -HK$0.4 Billion | 107.77% |
| 2015 | -HK$0.19 Billion | 99661.42% |
| 2014 | -HK$0.19 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -HK$0.86 Billion | 0.00% | 🇺🇸 USA |
 | HK$0.27 B | -132.06% | 🇺🇸 USA |
 | -HK$0.41 Billion | -52.51% | 🇮🇱 Israel |